Manuel Martínez-Lavín MD.
Internist and Rheumatologist.
Research interests:
Cardiovascular
involvement of rheumatic diseases and viceversa.
Addresses
Instituto Nacional de
Cardiologia Ignacio Chavez
Juan Badiano # 1
14080 Mexico D.F. MEXICO
Phone 55732911 ext 1175
Fax 55730994
Private Office:
Medica Sur
Puente de Piedra 150
14050 Mexico D.F. MEXICO
Phones 56064714 56065433
Fax 56064714
E-mail: mmlavin@infosel.net.mx
http://www.martinez-lavin.com/
Professional education
Medical School
Universidad Nacional Autonoma de Mexico.(UNAM) (1965-1971)
Postgraduate training
Internal Medicine. St. Louis University. St. Louis Missouri USA
(1972-1975).
Rheumatology. Scripps Clinic.
La Jolla California USA.
(1975-1977)
Degrees and Qualifications
Medical Doctor Degree. National Autonomous University of Mexico: 1971
License to practice Medicine in the state of Missouri USA. 1974
Appointed as Chief Resident of Internal Medicine. St. Louis City Hospital
USA. 1975
Internal Medicine Diploma. St. Louis University USA. 1975
Internal Medicine Certificate. American Board of Internal Medicine. 1975
License to practice Medicine in the State of California. 1975
Rheumatology Diploma. Scripps Clinic USA. 1977
Rheumatology Certificate. American Board of Internal Medicine. 1978
Rheumatology Certificate. Mexican Council of Rheumatology. 1978
Internal Medicine Certificate. Mexican Council of Internal Medicine. 1994
Academic Career
Clinical Researcher. Rheumatology Department, National Cardiology
Institute of Mexico. 1977 to date.
Chief Rheumatology Department at the National Cardiology Institute. 1983
to date.
Assistant Professor of the Rheumatology. National Autonomous University of
Mexico. 1980-1983.
Full Professor of the Rheumatology. National Autonomous University of
Mexico. 1983 to date.
Titular Researcher. National Health Institutes. (level C) 1989 to date.
National Investigator. National Investigation System. 1990 to date.
Academic Associations
American College of Physicians. 1975 to date
American College of Rheumatology. 1977 to date
Association of Interns and Scholarship Holders at the National Cardiology
Institute of Mexico. 1978 to date
Mexican Society of Rheumatology. 1978 to date
Mexican Society of Cardiology. 1979 to date
National Academy of Medicine. 1990 to date
Directive positions in academic societies
Mexican Rheumatology Council. President 1984-1985
Mexican Rheumatology Society. President 1987-1988
National Academy of Medicine. Secretary. 1994
Editorial board memberships
1. Archivos del Instituto de Cardiologia de Mexico. 1980 to date
2. Revista Mexicana de Reumatología 1987 to date
3. Journal of
Clinical Rheumatology 1997 to date
4. Clinical Rheumatology 2002 to date
Publications
1. Lisker R, Hernández A, Martínez-Lavín M, Mutchinik O, Armas C, Reyes P,
Robles Gil J. Geroderma osteodysplastica hereditaria: Report of three
affected brothers and literature review. AM J Med Gen 1979:3;389-395
2. Martínez-Lavín M,
Vaughan JH, Tan EM.
Autoantibodies and
the spectrum of Sjogren’s syndrome. Ann Intern Med 1979:92;185-190
3. Reyes PA, Martínez-Lavin M. Behcet’s syndrome: report of three cases
and recent literature review. Gac Med Mex 1979:115;573-577
4. Pineda E, Martínez-Lavín M. Hypertrophic osteoarthropathy in cyanotic
congenital heart disease. Report of two cases. Arch Inst Cardiol Mex
1980:50;151-155
5. Martínez-Lavín M, Vaughan JH, Holman KI, Smyth C. A comparison of
naproxen, indomethacin, and aspirin in osteoarthritis. J Rheumatol
1980:7;711-716
6. Gobaira J, Bobadilla M, Martínez-Lavín M. Oral manifestations of
rheumatic diseases. Acta Med Dom* 1980:2;33-36
7. Martínez-Lavín M, Bobadilla M, Casanova J, Attié F, Martínez M.
Hypertrophic osteoarthropathy in cyanotic congenital heart disease: its
prevalence and relationship to bypass of the lung. Arthritis Rheum
1982:25;1186-1193
8. Guadalajara JF, Martínez-Lavín M, Zusserman M, Solines L, Casanova JM,
Reyes P. The heart in scleroderma phono-echocardiographic study. Arch Inst
Cardiol Mex 1983:53;27-32
9. Martínez-Lavín M. Cardiopulmonary involvement in rheumatic diseases.
Arch Inst Cardiol Mex 1983:53;247-251
10. Martínez-Lavín M,
Buendía A, Delgado E, Reyes P, Amigo MC, Sabanés J, Zghaib A, Attié F,
Salinas L. A familial syndrome of pericarditis, arthritis and
camptodactyly.
N Engl J Med
1983:309;224-225
11. Martínez-Lavín M, Amigo MC, Castillejos G, Padilla L, Vintimilla F.
Coexistent gout and hypertrophic osteoarthropathy in patients with
cyanotic heart disease. J. Rheumatol 1984;11:832-834
12. Pop G, Romero L, Bialostozky D, Medrano G, Martínez-Lavín M. Cardiac
involvement in ankylosing spondylitis. Arch Inst Cardiol Mex 1985:55;63-67
13. Pineda C, Weisman M, Guerra A, Resnick D, Martínez-Lavín M The
skeletal manifestations of clubbing: A study in patients with cyanotic
heart disease and hypertrophic osteoarthropathy. Sem Arthritis Rheum
1985:14;263-267
14. Martínez-Lavín M, Castillejos G. Digital clubbing and hypertrophic
osteoarthropathy. Arch Inst Cardiol Mex 1985:55;415-419
15. Martínez-Lavín M.
Monoarthritis. Rev Mex Reumatol* 1986:1:34-36
16.
Nava-Zavala A, Amigo MC, Martínez-Lavín M. The heart in disseminated lupus
erythematosus Princ Cardiol* 1986:2;53-68
17. Martínez-Lavín M, Castillejos G. Ferritin and prostaglandins in
hypertrophic osteoarthropathy (letter). J Rheumatol 1986: 13;834-836
18. Martínez-Lavín M: Collagen and collagenosis. Rev Mex Reumatol*
1987:2,89-90
19. Amigo MC, Gómez T, Martínez-Lavín M. Oral aurotherapy in juvenil
rheumatoid arthritis. Rev
Mex Reumatol*.
20.
Castillejos G, Martínez-Lavin M. Discrepancy between arterial ferritin
levels and the presence of digital clubbing. Clin Rheumatol 1987 (2)
297-298
21. Pineda C, Martínez-Lavín M, Goobar J, Sartoris D, Clopton P, Resnick
D. Periostitis in hypertrophic osteoarthropathy. Am J Roentgenol AJR
1987:148;773-778
22. Cajigas JC, Amigo MC, Pineda C, Herrera R, Sánchez-Torres G,
Martínez-Lavín M. Association between Takayasu’s arteritis and cutaneous
polyarteritis nodosa. Am J Med 1987:82;382-384.
23. Martínez-Lavín M. Speech of the President of the Mexican Society of
Rheumatology (1987-1988).
Rev Mex Reumatol* 1988:3;51-52
24.
Martínez-Lavín M. Digital clubbing and hypertrophic osteoarthropathy: a
unifying hypothesis. J Rheumatol 1987:14;6-8
25. Martínez-Lavín M, Pineda C, Vázquez-Abad D. Platelets and clubbing
(letter). Lancet 1988:I;761.
26. Martínez-Lavín M, Pineda C, Valdéz T, Cajigas JC, Weisman M, Gerber N,
Steigler D: Primary hypertrophic osteoarthropathy. Sem Arthritis Rheum
1988:17;156-162
27. Martínez-Lavín M.
Rheumatic fever in Mexico.
New challenges, new
strategies. Arch Inst Cardiol Mex 1989:59;349-351
28. Martínez-Lavín M. Hypertrophic osteopathy, new perspectives. Rev Esp
Reumatol* 1989:16;79-80
29. García A, Martínez-Lavín M. Hypertrophic osteoarthropathy of the
animals. Rev Mex Reumatol*
1989:4,146-148
30. Vázquez-Abad
D, Pineda C, Martínez-Lavín M. Digital clubbing: a numerical assessment of
the deformity. J Rheumatol 1989:16;518-520
31. Pineda C, Fonseca C, Martínez-Lavín M. The spectrum of soft tissue and
skeletal abnormalities of hypertrophic osteoarthropathy. J. Rheumatol
1989:16,518-520
32. Martínez-Lavín M, Pineda C. Digital clubbing (letter). Lancet
1990:1;1444
33. Martínez-Lavín M. Naproxen indomethacin and aspirin in the treatment
of osteoarthritis. A comparison using a modification of the double-blind
crossover study. Clin Therap* 1991:13;suppl A. 16-19
34. Vázquez-Abad D, Martínez-Lavín M. Macrothrombocytes in the peripheral
circulation of patients with cardiogenic hypertrophic osteoarthropathy.
Clin Exp Rheumatol 1991:9;59-62
35. Martínez-Lavín M: The etiology of digital clubbing. Gac Med Mex
1991;127:221-225
36. Morales E, Pineda C, Martínez-Lavín M. Takayasu’s arteritis in
children. J Rheumatol 1991:18;1081-1084
37. Martínez-Lavín M Recent findings in hypertrophic osteoarthropathy.
Contemp Intern Med* 1992:75-85
38. Matucci-Cerinic M, Martínez-Lavín M, Rojo F, Fonseca C, Kahaleh B. von
Willebrand factor antigen in hypertrophic osteoarthropathy. J Rheumatol
1992:19;765-767
39. Martínez-Lavín M. Cardiogenic hypertrophic osteoarthropathy. Clin Exp
Rheumatol 1992:10;S-7-22
40. Martínez-Lavín M. Pathogenesis of hypertrophic osteoarthropathy. Clin
Exp Rheumatol 1992:10;S-7;49-50
41. Martínez-Lavín M, Pineda C, Navarro C, Buendía A, Zabal C. Primary
hypertrophic osteoarthropathy; another heritable disorder associated to
patent ductus arteriosus.
Pediatric Cardiol
1993:14;181-182
42. Amigo MC, Martínez-Lavín M, Reyes PA.
Acute rheumatic
fever. Rheum Dis Clin North Am 1993:19;333-350
43. Martínez-Lavín M, Matucci-Cerinic M, Jajic I, Pineda C. Workshop
report. Hypertrophic osteoarthropathy, a consensus on its definition,
classification, assessment and diagnostic criteria. J Rheumatol
1993:20;1386-1387
44. Pineda C, Arana B, Martínez-Lavín M, Dábague J. Frozen shoulder
triggered by cardiac catheterization via the brachial artery. Am J Med
1994:96;90-91
45. Mondragón-Ramírez G, Bochicchio T, García Torres R, Amigo MC,
Martínez-Lavín M, Reyes P, Herrera-Acosta J. Recurrent renal thrombotic
angiopathy after kidney transplantation in two patients with primary
antiphospholipid syndrome (PAPS). Clin Transp 1994:8;93-96
46. Martínez-Lavín M: Elucidation of digital clubbing may help in
understanding the pathogenesis of pulmonary hypertension associated with
congenital heart defects.
Cardiol Young 1994:4;228-231
47. Martínez-Lavín M, Amigo MC.
The value of Jones
criteria in the recognition of acute rheumatic fever fifty years later.
Clin Exp Rheumatol 1994:12;355-356
48. Hermosillo AG, Ortiz R, Dábague J, Casanova JM, Martínez-Lavín M.
Autonomic dysfunction in diffuse scleroderma vs CREST: an assesment by
computerized heart rate variability. J Rheumatol 1994:21,1849-1854
49. Martínez-Lavín M, Mansilla J, Pineda C, Pijoán C. Evidence of
hypertrophic osteoarthropathy in human skeletal remains from Prehispanic
Mesoamerica. Ann Intern Med 1994:120:238-241
50. Martínez-Lavín M, Fonseca C, Amigo MC, Nava A, Reyes PA, Ruiz
Arguelles A. Antiphospholipid syndrome in patients with cyanotic heart
disease. Clin Exp Rheumatol 1995:13;489-491
51. Martínez-Lavín M, Mansilla J, Pineda C, Pijoán C. Ankylosing
spondylitis is indigenous to Mesoamerica. J Rheumatol 1995;22:2327-2330
52. Martínez-Lavín M. Hypertrophic osteoarthropathy. Curr Opin Rheumatol
1997 ; 9 : 83-86
53. Martínez-Lavín M, Hermosillo AG, Mendoza C, Ortiz R, Cajigas JC,
Pineda C, Nava A, Vallejo M. Orthostatic sympathetic derangement in
individuals with fibromyalgia. J. Rheumatol 1997 ;24 : 714-718
54. Martínez-Lavín M, Buendía A, Pineda C. Hypertension in children.
(letter) N Engl J Med 1997 ; 336 : 1975-76
55. Martínez-Lavín M, Vargas AS, Cabré C, Nava A, Amigo MC, Pineda C.
Features of hypertrophic osteoarthropathy in patients with POEMS syndrome
: a metaanalysis. J Rheumatol 1997 ;24 :2267-68
56. Martínez-Lavín M, Hermosillo AG. Orthostatic sympathetic derangement
of baroreflex in patients with fibromyalgia (response to a letter) J
Rheumatol 1998 ; 25 : 823-25
57. Pineda C, Mansilla C, Pijoán C, Fernandez S, Martínez-Lavín M.
Radiographs of an ancient mortuary bundle supports theory for the new
world origin of syphilis. Am J Roentgenol (AJR) 1998 ;171 :321-324
58. Martínez-Lavín M,
Hermosillo AG, Rosas M, Soto ME.
Circadian studies of
autonomic nervous tone in patients with fibromyalgia. A heart rate
variability analysis.
Arthritis Rheum 1998 ; 41 :1966-1971
59. Pineda C, Gurza A, Rodriguez MA, Vazquez J, Castañon C, Silveira LH,
Martínez-Lavín M. Revised diagnostic criteria for the Marfan syndrome.
A
clinical-radiographic assay. J Clin Rheumatol 1998; 278-286
60. Yamamoto-Furusho JK, Rodriguez-Reyna T, Zuñiga J, Vargas-Alarcón G,
Martínez-Lavín M, Granados J. Immunogenetic study of 3 families with
probands of primary hypertrophic osteoarthropathy. Clin Exp Rheumatol 1998
;16 :629-30
61. Pineda C, Mansilla J, Pijoan C, Martínez-Lavín M. Origin of syphilis
(response to a letter) Am J Roentgenol 1999;172:1138-39
62. Moreno-Sánchez R, Bravo C, Vásquez C, Ayala G, Silveira LH,
Martínez-Lavín M. Inhibition and uncoupling of oxidative phosphorylation
by nonsteroidal anti-inflammatory drugs. Study in mitochondria,
submitochondrial particles, cells, and whole heart. Biochem Pharmacol
1999;57:743-752
63. Buendía A, Attié F, Martínez-Lavín M. The
pericarditis-arthritis-camptodactyly syndrome. A under-recognized cause of
pericardial constriction in children. Cardiol Young 1999
64. Martínez-Lavín M. Pineda C. Recognition of hypertrophic
osteoarthropathy in skeletal remains (letter).
J Rheumatol 1999; 26: 1640-42
65. Martínez-Lavín M, León A, Hermosillo AG, Pineda C, Amigo MC: The
dysautonomia of fibromyalgia may simulate lupus.
J Clin Rheumatol
1999; 5: 332-334
66. Silveira LH, Martínez-Lavín M, Pineda C, Fonseca MC, Navarro C, Nava
A. Vascular endothelial growth factor and hypertrophic osteoarthropathy.
Clin Exp Rheumatol 2000; 18: 57-62
67. Martinez-Lavin M, Hermosillo A G. Autonomic nervous system dysfunction
may explain the multisystem features of fibromyalgia. Semin Arthritis
Rheum 2000; 29: 197-199
68. Martinez-Lavin M, Amigo M C, Coindreau J, Canoso J. Fibromyalgia in
Frida Kahlo's life and art. Arthritis Rheum 2000; 43: 708-709
69. Cantu C, Pineda C, Barinagarrementeria F, Salgado P, Gurza A, De Pablo
P, Espinosa R, Martinez-Lavin M. Non-invasive cerebrovascular assessment
of Takayasu's arteritis. Stroke 2000; 31: 2197-202
70. Martinez-Lavin M. Is fibromyalgia a generalized sympathetic dystrophy?
Clin Exp Rheumatol 2001;19:1-3
71. Martínez-Lavín M. Overlap of fibromyalgia with other medical
conditions. Curr Pain Headache Rep 2001;5:347-50
72. Martínez-Lavín M,
Pineda C. Contribuciones de la Reumatología Mexicana al conocimiento
médico. Osteoartropatía hipertrófica. Rev Mex Reumat 2001;16:223-26*
73. Martinez-Lavin M, Vidal
M, Barbosa RE, Pineda C, Casanova JM, Nava A. Norepinephrine-evoked pain
in fibromyalgia.
A randomised pilot
study (ISCRTN 70707830).
BMC Musculoskel Disord 2002;3:2 (www.biomedcentral.com/1471-2474/3/2).
74. Martínez-Lavín M,
Hermosillo AG. La fibromialgia y el sistema nervioso autónomo.
Gac Med Mex
2002;138:55-56
75. Martinez-Lavin
M. Autonomic nervous system in fibromyalgia. J Musculoskel Pain 2002
10:221-228
76. Martinez-Lavin
M. Management of dysautonomia in fibromyalgia. Rheum Dis Clin North Am
2002 28:379-87
77. Martínez-Lavín
M. A novel holistic explanation for the fibromyalgia enigma. Autonomic
nervous system dysfunction.
Fibromyalgia Frontiers
2002;10;3-6 (
http://www.fmpartnership.org/Lavin article.htm
)
78. Amigo MC, Vidal M,
Martínez-Lavín M. A minimally invasive lip biospy technique (letter).
J Clin
Rheumatol 2002;8:236
79. Martínez-Lavín
M, López S, Medina M, Nava A. The use of the Leeds Assessment of
Neuropathic Symptoms and Signs (LANSS) questionnaire in patients with
fibromyalgia. Semin Arthritis Rheum 2003.
80. Kooh M,
Martínez-Lavín M, Meza S, Martín-del-Campo A, Hermosillo Ag, Pineda C,
Nava A, Amigo MC, Drucker-Colín R. Concurrent heart rate variability and
polysomnography analyses in patients with fibromyalgia. Clin Exp Rheumatol
2003
* = Journals not included in Index Medicus
Thesis conduction
1. Dr. María Graciela Bobadilla Pichardo.
Prevalence of
hypertrophic osteoarthropathy in cyanotic congenital heart disease.
Specialist in Rheumatology.
UNAM. 1981.
2. Dr. Arnulfo Hernán Nava Zavala.
Arterial hypertension
in generalized lupus erythematosus. Specialist in Rheumatology.
UNAM 1989.
3. Dr. Enrique Cuitláhuac Morales Villegas.
Takayasu’s arteritis
in children. Specialist in Cardiology.
UNAM 1989
4. Dr. María Dolores Vázquez Abad.
Presence of
hypertrophic osteoarthropathy in patients with cyanotic congenital heart
disease in relation to abnormal morphology of platelets. Specialist in
Rheumatology. UNAM 1989
5. Dr. Gustavo Esteban Lugo Zamudio.
Discrimination
between infectious endocarditis and rheumatic fever reactivation.
Specialist in Rheumatology., UNAM 1991
6. Dr. Janete Dábague
Guzmán.
Autonomic dysfunction in systemic sclerosis and CREST syndrome assessed by
high resolution electrocardiogram. Specialist in Rheumatology.
UNAM 1994
7. Dr. Rolando Espinosa Morales.
Randomized double
blind comparative study, of two months on the efficacy and tolerance to
aceclofenac vs. piroxicam in the treatment of osteoarthritis of the knee.
Specialist in Rheumatology.
UNAM 1994
8. Dr. María del Carmen Fonseca Gutiérrez.
Hepatic hypertrophic
osteoarthropathy. Specialist in Rheumatology.
UNAM 1995.
9. Dr. Rebeca Padilla Ortiz.
Three month
comparative study, at random, double blind, parallel, on the efficiency
and tolerance to aceclofenac vs. tenoxicam in the treatment of rheumatoid
arthritis. Specialist in Rheumatology.
UNAM. 1995
10. Dr. Maria Cristina Mendoza Becerra.
Spectral analysis of
heart rate variability in fibromyalgia. Specialist in Rheumatology.
UNAM 1997
11. Dr. Ana Sofía Vargas Avilés.
A meta-analysis
suggests that POEMS syndrome and hypertrophic osteoarthropathy share
clinical and pathogenic features. Specialist in Rheumatology. UNAM 1997
12. Dr. Minh Kooh. Concurrent studies of autonomic nervous system function
and polysomnography in patients with fibromyalgia. 1999. Thesis for Social
Service in Investigation
13. Dr. Mirna Muñoz.
Fatal familial
insomnia as a model to study the pathogenesis of fibromyalgia/chronic
fatigue. 1999. Specialist in Rheumatology. Ministry of Foreing Affairs.
Authoring of textbook chapters
1. Martínez-Lavín M. Hypertrophic osteoarthropathy. In: Schumacher R,
Klippel J, Koopman G, eds. Primer in the Rheumatic diseases. The Arthritis
Foundation. Atlanta. 1989, 1993,1997 and 2001 editions.
2. Martínez-Lavín M. Hypertrophic osteoarthropathy. In: Rheumatology.
Gower Medical Ed. London UK. 1993,1997 and 2001 editions.
3. Vázquez-Abad D, Pineda
C, Martínez-Lavín M. Hypertrophic Osteoarthropathy. In: Iglesias A Ed.
Skeletal
metabolic disease. National Health Institutes.
Bogota Colombia 1993.
4. Martínez-Lavín M. Hypertrophic Osteoarthropathy. In: Pascual E,
Rodríguez-Valverde V, carbonell J, Gómez-Reino J eds.
Rheumatology.
Locomotive and connective tissue disease.
ARAN Ed. Madrid.
1998
5. Martínez-Lavín M: Backache and regional painful syndromes. In: Uribe M:
Ed. Treatise on Internal Medicine.
Ed. Panamericana Mexico D.F.
1995.